PortfoliosLab logoPortfoliosLab logo
IBB vs. SCHD
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBB vs. SCHD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Nasdaq Biotechnology ETF (IBB) and Schwab U.S. Dividend Equity ETF (SCHD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBB achieves a -1.02% return, which is significantly lower than SCHD's 18.71% return. Over the past 10 years, IBB has underperformed SCHD with an annualized return of 6.75%, while SCHD has yielded a comparatively higher 12.65% annualized return.


IBB

1D
-0.90%
1M
-1.78%
YTD
-1.02%
6M
-1.60%
1Y
31.79%
3Y*
9.31%
5Y*
1.05%
10Y*
6.75%

SCHD

1D
-0.03%
1M
2.12%
YTD
18.71%
6M
19.28%
1Y
26.37%
3Y*
14.73%
5Y*
8.49%
10Y*
12.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBB vs. SCHD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBB
iShares Nasdaq Biotechnology ETF
-1.02%27.98%-2.41%3.76%-13.69%0.95%26.01%25.42%-9.53%21.08%
SCHD
Schwab U.S. Dividend Equity ETF
18.71%4.34%11.66%4.54%-3.26%29.87%15.03%27.29%-5.56%20.85%

Correlation

The correlation between IBB and SCHD is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.45

Correlation (3Y)
Calculated over the trailing 3-year period

0.57

Correlation (5Y)
Calculated over the trailing 5-year period

0.57

Correlation (10Y)
Calculated over the trailing 10-year period

0.52

Correlation (All Time)
Calculated using the full available price history since Oct 21, 2011

0.54

The correlation between IBB and SCHD shifts across timeframes, from 0.45 (1 year) to 0.57 (3 years), reflecting how their relationship changes across market environments.

IBB vs. SCHD - Sectors Allocation Comparison


Sectors
IBB
SCHD

Healthcare

100.0%
18.8%

Basic Materials

-

1.2%

Communication Services

-

6.3%

Consumer Cyclical

-

6.3%

Consumer Defensive

-

19.2%

Energy

-

16.2%

Financial Services

-

9.3%

Industrials

-

7.5%

Real Estate

-

-

Technology

-

16.4%

Utilities

-

0.0%

Healthcare

IBB
100.0%
SCHD
18.8%

Basic Materials

IBB

-

SCHD
1.2%

Communication Services

IBB

-

SCHD
6.3%

Consumer Cyclical

IBB

-

SCHD
6.3%

Consumer Defensive

IBB

-

SCHD
19.2%

Energy

IBB

-

SCHD
16.2%

Financial Services

IBB

-

SCHD
9.3%

Industrials

IBB

-

SCHD
7.5%

Real Estate

IBB

-

SCHD

-

Technology

IBB

-

SCHD
16.4%

Utilities

IBB

-

SCHD
0.0%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBB vs. SCHD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBB
IBB Risk / Return Rank: 5757
Overall Rank
IBB Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
IBB Sortino Ratio Rank: 5353
Sortino Ratio Rank
IBB Omega Ratio Rank: 4747
Omega Ratio Rank
IBB Calmar Ratio Rank: 7272
Calmar Ratio Rank
IBB Martin Ratio Rank: 6363
Martin Ratio Rank

SCHD
SCHD Risk / Return Rank: 8585
Overall Rank
SCHD Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
SCHD Sortino Ratio Rank: 8989
Sortino Ratio Rank
SCHD Omega Ratio Rank: 8181
Omega Ratio Rank
SCHD Calmar Ratio Rank: 9292
Calmar Ratio Rank
SCHD Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBB vs. SCHD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBBSCHDDifference
Sharpe ratioReturn per unit of total volatility

-0.83

Sortino ratioReturn per unit of downside risk

-1.43

Omega ratioGain probability vs. loss probability

1.27

1.43

-0.16

Calmar ratioReturn relative to maximum drawdown

3.32

5.74

-2.43

Martin ratioReturn relative to average drawdown

10.36

14.06

-3.70

IBB vs. SCHD - Sharpe Ratio Comparison

The current IBB Sharpe Ratio is 1.59, which is lower than the SCHD Sharpe Ratio of 2.43. The chart below compares the historical Sharpe Ratios of IBB and SCHD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBBSCHDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.59

2.43

-0.83

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.05

0.59

-0.55

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

0.76

-0.47

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.86

-0.60

Drawdowns

IBB vs. SCHD - Drawdown Comparison

The maximum IBB drawdown since its inception was -62.85%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for IBB and SCHD.


Loading charts...

Drawdown Indicators


IBBSCHDDifference

Max Drawdown

Largest peak-to-trough decline

-62.85%

-33.37%

-29.48%

Max Drawdown (1Y)

Largest decline over 1 year

-9.63%

-4.61%

-5.02%

Max Drawdown (3Y)

Largest decline over 3 years

-24.85%

-16.13%

-8.72%

Max Drawdown (5Y)

Largest decline over 5 years

-39.82%

-16.85%

-22.97%

Max Drawdown (10Y)

Largest decline over 10 years

-39.82%

-33.37%

-6.45%

Current Drawdown

Current decline from peak

-5.97%

-1.64%

-4.33%

Average Drawdown

Average peak-to-trough decline

-21.17%

-3.32%

-17.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.08%

1.88%

+1.20%

Volatility

IBB vs. SCHD - Volatility Comparison

iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.87% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 2.83%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBBSCHDDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.87%

2.83%

+4.04%

Volatility (6M)

Calculated over the trailing 6-month period

15.57%

7.60%

+7.97%

Volatility (1Y)

Calculated over the trailing 1-year period

20.10%

10.94%

+9.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.97%

14.38%

+7.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.22%

16.72%

+6.50%

IBB vs. SCHD - Expense Ratio Comparison

IBB has a 0.47% expense ratio, which is higher than SCHD's 0.06% expense ratio.


Dividends

IBB vs. SCHD - Dividend Comparison

IBB's dividend yield for the trailing twelve months is around 0.23%, less than SCHD's 3.27% yield.


PositionTTM20252024202320222021202020192018201720162015
IBB
iShares Nasdaq Biotechnology ETF
0.23%0.23%0.29%0.26%0.31%0.21%0.21%0.33%0.20%0.30%0.19%0.03%
SCHD
Schwab U.S. Dividend Equity ETF
3.27%3.82%3.64%3.49%3.39%2.78%3.16%2.98%3.06%2.63%2.89%2.97%

Frequently Asked Questions


IBB and SCHD have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBB has higher volatility (6.87%) compared to SCHD (2.83%). In terms of maximum drawdown, IBB dropped -62.85% vs SCHD's -33.37%.

On 10-year performance, SCHD leads with 12.65% vs 6.75% for IBB. On fees, SCHD is cheaper at 0.06% per year. On volatility, SCHD has been the lower-risk option at 2.83%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SCHD has performed better with a 12.65% return vs 6.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SCHD is cheaper with a 0.06% expense ratio, compared with 0.47% for IBB.

SCHD has the higher dividend yield at 3.27%, compared with 0.23% for IBB.

IBB is categorized as Health & Biotech Equities, while SCHD is Dividend. IBB tracks NASDAQ Biotechnology Index, while SCHD tracks Dow Jones U.S. Dividend 100 Index. They also come from different issuers: iShares and Charles Schwab. Their fees differ too: 0.47% for IBB and 0.06% for SCHD.

SCHD currently has the higher Sharpe Ratio (2.43 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBB and SCHD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer